Daily Briefing: El Niño, Lab Mice, AI Citations, and Mental Health Research

The scientific community is closely monitoring the potential emergence of a "super" El Niño later this year, with forecasters predicting one of the strongest weather patterns in recent decades. This phenomenon could unleash a cascade of extreme weather events globally, including severe floods, prolonged droughts, and record-high temperatures. However, a degree of uncertainty persists, as atmospheric factors like winds could either intensify the ocean heat or temper it, thereby weakening the El Niño's potential strength. Experts anticipate greater clarity in the coming weeks, once they navigate past the challenging 'spring predictability barrier,' a period notorious for its difficulty in accurate long-range forecasting. In a significant finding that could impact biomedical research worldwide, a genetic analysis has uncovered alarming inconsistencies in nearly half (47%) of lab-mouse strains distributed globally. The study revealed mismatches between the reported names of these strains and their actual genetic makeup. Scientists warn that such discrepancies have the potential to severely compromise the integrity of countless mouse studies, undermining their conclusions and potentially leading to misinterpretations of disease mechanisms. Immunologist Daniel Rawle emphasized the gravity of the situation, stating, "This study is another wake-up call for biomedical research. If we don’t fully understand the genetics of the mice we’re using, we risk misinterpreting how diseases actually work." The burgeoning influence of artificial intelligence in academia is raising new concerns, particularly regarding the proliferation of AI-hallucinated citations. An audit of 2.5 million papers and preprints published in 2025 revealed a notable number of such bogus references, with social-science preprints showing the highest proportion. This issue intertwines with a broader debate among researchers about the responsible sharing of raw data. As AI algorithms increasingly scrape open-access databases for training fodder, some scientists advocate for tighter controls to prevent data misuse, while others argue that the principles of openness remain paramount and that restrictions might not deter malicious actors. In a significant shift in medical understanding, a recent review by Cochrane, a highly respected group for medical evidence, suggests that testing for prostate-specific antigen (PSA) "likely reduces the risk of dying" from prostate cancer. This finding marks a reversal from previous Cochrane reviews in 2006 and 2013, driven by new data from two large trials involving 250,000 people and extended data from four older trials. While the number of lives saved is reported to be small, the updated guidance offers new hope. Concurrently, the US National Institutes of Health (NIH) faces a critical staffing shortage, particularly among grants management specialists (GMSs), due to layoffs and resignations in 2025. This shortfall, despite a $47-billion budget, is forcing NIH to prioritize existing grant payments over the review and approval of new research funding. The global challenge of mental health continues to be a pressing concern, with an estimated one billion people worldwide – roughly one in seven – living with a mental-health condition. A significant portion of these individuals struggle to access the necessary treatment, care, or support. In a concerted effort to address this crisis and elevate the field of mental health research, Wellcome, in partnership with Nature, has announced a prestigious new award: The Wellcome Prize for Mental Health Science with Nature. This prize will grant US$1 million to an overall winner for developing innovative strategies or treatments that demonstrably improve mental health outcomes, with three additional finalists each receiving $250,000. Actor David Harewood, a vocal advocate for mental health, highlighted the global relevance of the prize, noting that "mental health knows no borders." The urgent global battle against antibiotic resistance is driving researchers to explore novel and even unconventional avenues for discovering new antimicrobial compounds. Leveraging the power of artificial intelligence, scientists are sifting through vast datasets to identify potential candidates. Beyond computational approaches, some researchers are turning to unexpected sources. A Nature filmmaker documented one such endeavor, where a researcher, in a remote graveyard in Northern Ireland, discovered antibiotic-producing bacteria in the soil near the grave of a faith healer. This innovative approach underscores the critical need for diverse strategies in the ongoing quest to replenish our dwindling arsenal of effective antibiotics.